RECKITT BENCKISER GROUP PLC (3RB.DE) Stock Price, Forecast & Analysis
Europe - FRA:3RB - GB00B24CGK77 - Common Stock
3RB.DE Key Statistics, Chart & Performance
The current stock price of 3RB.DE is 66.18 EUR. In the past month the price increased by 2.1%. In the past year, price increased by 9.93%.
3RB.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRG.DE | PROCTER & GAMBLE CO/THE | 21.91 | 305.57B | ||
| CPA.DE | COLGATE-PALMOLIVE CO | 20.88 | 53.33B | ||
| KMY.DE | KIMBERLY-CLARK CORP | 17.4 | 34.35B | ||
| HEN3.DE | HENKEL AG & CO KGAA VOR-PREF | 12.99 | 30.90B | ||
| 1HEN.MI | HENKEL AG & CO KGAA | 12.08 | 28.73B | ||
| HEN.DE | HENKEL AG & CO KGAA | 11.95 | 28.42B | ||
| MLGAL.PA | GALEO CONCEPT | N/A | 1.55M |
Related stock screener links
About 3RB.DE
Company Profile
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. The company is headquartered in Slough, Berkshire and currently employs 37,900 full-time employees. The company went IPO on 2007-10-23. The firm's operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.
Company Info
RECKITT BENCKISER GROUP PLC
103-105 Bath Road
SLOUGH BERKSHIRE GB
Employees: 37900
Phone: 441753217800
RECKITT BENCKISER GROUP PLC / 3RB.DE FAQ
What does RECKITT BENCKISER GROUP PLC do?
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. The company is headquartered in Slough, Berkshire and currently employs 37,900 full-time employees. The company went IPO on 2007-10-23. The firm's operating segments comprise the Hygiene, Health, and Nutrition business. The Hygiene portfolio works to eliminate dirt, germs, pests, and odors with products such as Lysol, Finish, Air Wick, Harpic and Mortein. The Company’s Health portfolio offers various solutions that provide pain relief, protection, hygiene, and personal care to households across the world, through brands like Dettol, Durex, Gaviscon, Nurofen, Mucinex, Strepsils and Veet. The Nutrition business includes its infant and child nutrition, its adult nutrition and its range of vitamins, minerals, and supplements (VMS). Brands under Nutrition business include Enfa, Enfamil, Nutramigen, Airborne, Move Free and Neuriva. The Company’s brands also include Dettol, Lysol, Harpic, Finish, Durex, Mucinex, Enfamil and Move Free and more.
What is the stock price of RECKITT BENCKISER GROUP PLC today?
The current stock price of 3RB.DE is 66.18 EUR. The price decreased by -0.3% in the last trading session.
Does RECKITT BENCKISER GROUP PLC pay dividends?
RECKITT BENCKISER GROUP PLC (3RB.DE) has a dividend yield of 3.54%. The yearly dividend amount is currently 2.24.
What is the ChartMill rating of RECKITT BENCKISER GROUP PLC stock?
3RB.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for 3RB.DE stock?
27 analysts have analysed 3RB.DE and the average price target is 72.18 EUR. This implies a price increase of 9.07% is expected in the next year compared to the current price of 66.18.
Should I buy 3RB stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 3RB.DE.
3RB.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to 3RB.DE. When comparing the yearly performance of all stocks, 3RB.DE turns out to be only a medium performer in the overall market: it outperformed 48.58% of all stocks.
3RB.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 3RB.DE. 3RB.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
3RB.DE Financial Highlights
Over the last trailing twelve months 3RB.DE reported a non-GAAP Earnings per Share(EPS) of 4.04. The EPS increased by 14.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.88% | ||
| ROA | 5.05% | ||
| ROE | 19.68% | ||
| Debt/Equity | 1.26 |
3RB.DE Forecast & Estimates
27 analysts have analysed 3RB.DE and the average price target is 72.18 EUR. This implies a price increase of 9.07% is expected in the next year compared to the current price of 66.18.
For the next year, analysts expect an EPS growth of 3.23% and a revenue growth -0.23% for 3RB.DE